Tri Locum Partners LP Avadel Pharmaceuticals PLC Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$14.06 - $18.82 $98 - $131
7 Added 0.0%
1,189,518 $16.7 Million
Q1 2024

May 15, 2024
BUY
$12.55 - $17.22 $4.39 Million - $6.02 Million
349,578 Added 41.62%
1,189,511 $20.1 Million
Q4 2023

Feb 14, 2024
SELL
$9.64 - $14.59 $1.38 Million - $2.1 Million
-143,669 Reduced 14.61%
839,933 $11.9 Million
Q3 2023

Nov 14, 2023
SELL
$10.3 - $15.99 $575,481 - $893,393
-55,872 Reduced 5.38%
983,602 $10.1 Million
Q2 2023

Aug 14, 2023
SELL
$8.48 - $16.48 $2.44 Million - $4.74 Million
-287,623 Reduced 21.67%
1,039,474 $17.1 Million
Q1 2023

May 15, 2023
BUY
$6.41 - $9.95 $4.12 Million - $6.39 Million
642,541 Added 93.86%
1,327,097 $12.2 Million
Q4 2022

Feb 14, 2023
BUY
$5.02 - $10.0 $3.44 Million - $6.85 Million
684,556 New
684,556 $4.9 Million
Q4 2021

Feb 14, 2022
SELL
$7.34 - $11.18 $1.09 Million - $1.66 Million
-148,355 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.49 - $9.91 $1.07 Million - $1.64 Million
-165,440 Reduced 52.72%
148,355 $1.45 Million
Q2 2021

Aug 16, 2021
BUY
$6.73 - $9.05 $1.03 Million - $1.39 Million
153,539 Added 95.81%
313,795 $2.11 Million
Q1 2021

May 17, 2021
BUY
$6.61 - $10.07 $1.06 Million - $1.61 Million
160,256 New
160,256 $1.45 Million

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $661M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email